Apolipoproteínas y deterioro cognitivo

Actas Espanolas de Psiquiatria

Volumn 26, Issue 6, 1998, Pages 380-390

  Bartres Faz D ^a   Clemente, I ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Aging; Apolipoproteins; Cerebrovascular disease; Memory; Neuropsychology

Indexed keywords

APOLIPOPROTEIN E;

AGED; AGING; BRAIN; BRAIN DISEASE; COGNITIVE DEFECT; FEMALE; GENETICS; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PHENOTYPE; REVIEW;

AGED; AGING; APOLIPOPROTEINS E; BRAIN; BRAIN DISEASES; COGNITION DISORDERS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; PHENOTYPE;

EID: 17544387488     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (83)

1. Tonegawa S, Chen C. Molecular genetic analysis of synaptic plasticity activity-dependent neural development, learning, and memory in the mammalian brain». Annu Rev Neurosci 1997;20:157-84.
2. Gómez-Gerique, J. Lipoproteínas plasmáticas. Barcelona: Boehringer Mannheim SA; 1991.
3. Elshourbagy N A, Liao WL, Mahley RW, Taylor JM. Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and maromosets. Proc Natl Acad Sci USA 1985;82:203-7.
4. Pitas RE, Boyle JK, Lee SH, FOS D, Mahley RW. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E containing lipoproteins. Biochem Biophys Acta 1987;917:148-61.
5. Das HK, McPherson J, Bruns AP, Karathanasisi SK, Breslow JS. Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E Gene. J Biol Chem 1985;260(10):6240-7.
6. Mahley RW. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-30.
7. Scott J. Apolipoprotein E and Alzheimer's disease. The Lancet 1993;342:696.
8. Martínez Lage JM. Marcadores diagnósticos en la enfermedad de Alzheimer. Med Clin (Barc) 1997;109:625-8.
9. Curts M, Van Broeckhoven C. Presenilin mutations in Alzhiemer's disease. Hum Mut 1998;11:183-90.
10. Strittmatter WJ, Saunders AM, Schmechel D, Periack-Vance M, Enghild J, Roses AD. Apolipoprotein E: High-avidity binding to βA amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993;90:1977-81.
11. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. The Lancet 1993;342:697-9.
12. Saunders AM, Schmader K, Breitner JCS, Benson MD, Brown WT, Goldfarb L, Goldgaber D, Manwaring MG, Szymanski MH, McCown N, Dole KC, Schmechel DE, Strittmatter WJ, Pericak-Vance MA, Roses AD. Apolipoprotein ε4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. The Lancet 1993;342:710-1.
13. Corder EH, Saunders WJ, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA. Gene dose of Apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-3.
14. Yoshizawa T, Yamakawa-Kobayashi K, Komatsuzaki Y, Arinami T, Oguni E, Mizusawa H, Shoji S, Hmaguchi H. Dose-dependent association of apolipoprotein E allele ε4 with late-onset, sporadic Alzheimer's disease. Ann Neurol 1994;36:656-9.
15. Schellenberg GD, Boehnke M, Wijsman EM, Moore DK, Martin GM, Bird TD. Genetic association and linkage analysis of the apolipoprotein CII locus and familial Alzheimer's disease. Ann Neurol 1992;31(2): 223-7.
16. Tsuda T, López R, Rogaeva EA, Freedman M, Rogaev E, Drachman D, Pollen D, Haines J, Liang Y, Crapper McLachlan DR, St George-Hyslop P. Are the associations between Alzheimer's disease and polymorphisms in the apolipoprotein E and the apolipoprotein CII genes due to linkage disequilibrium. Ann Neurol 1994;36:97-100.
17. Bullido MJ, Artiga MJ, Recuero M, Sastre I, García MA, Aidudo J, Lendon C, Han SW, Morris JC, Frank A, Vázquez J, Goate A, Valdivieso E. A polymorphism in the regulatory region of ApoE associated with risk for Alzheimer's dementia. Nat Genet 1998;18(1):69-71.
18. Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutz-feldt-Jakob disease. Brain Res 1991;541:163-6.
19. Wisniewski T, Frangione B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neuroscience Letters 1992;135:235-8.
20. Richey PL, Siedlak SL, Smith MA, Perry G. Apolipoprotein E interaction with the neurofibrilary tangles and senile plaques in Alzheimer disease: Implications for diesase pathogenesis. Biochem Biophys Res Commun 1995;208(2):657-63.
21. Sanan DA, Weisgraber KH, Russell SJ, Mahley RW, Huang D, Saunders A, Schmechel D, Wisniewski T, Frangione B, Roses AD, Strittmatter J. Apolipoprotein E associates with β amyloid peptide of Alzheimer's disease to form novel monofibrils. J Clin Invest 1994;94:860-9.
22. Strittmatter WJ, Weisgraber KH, Goedert M, Saunders AM, Huang D, Corder EH, Dong LM, Jakes R, Alberts MJ, Gilbert JR, Han SL, Hulette C, Einstein G, Schmechel E, Pericak-Vance MA, Roses AD. Hypothesis: microtubule instability and paried helical filament formation in the Alzheimer's disease brain are related to aplipoprotein E genotype. Exp Neurol 1994;125:163-71.
23. Oyama F, Shimada H, Oyama R, Ihara Y. Apolipoprotein E genotype, Alzhemer's pathologies and related gene expression in the aged population. Mol Brain Res 1995;29:92-8.
24. Polvikoski T, Sulkava R, Maltia M, Karnulainen K, Vuorio A, Verkkoniemi A, Niinisto L, Halonen P, Kontula K. Apolipoprotein E, dementia and cortical deposition of β-amyloid protein. N Engl J Med 1995; 9:1242-7.
25. Yamada M, Yoshinori I, Suematsu N, Otomo E, Matsushita M. Apolipoprotein E genotype in elderly nondemented subjects without senile changes in the brain. Ann Neurol 1996;40(2):243-5.
26. Soininen H, Riekkinen PJ. Apolipoprotein E, memory and Alzheimer's disease. Trends in Neuroscience 1996;19(6):224-8.
27. Lehtovirta M, Soininen H, Helisalmi S, Manneramaa A, Helkala EL, Hartikainen P, Hänninen T, Ryynänen M, Riekkinen PJ. Clinical and neurpsychological characteristics in familial and sporadic Alzheimer's disease: Relation to apolipoprotein E polymorphism. Neurology 1996;46:413-9.
28. Reed T, Carmelli D, Swan GE, Breitner JCS, Welsh KA, Jarvik GP, Deeb S, Auwerx J. Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E ε4 allele. Arch Neurol 1994;51:1189-92.
29. Soininen H, Partanen K, Pitkänen A, Hallikainen M, Hänninen T, Helisalmi S, Mannermaa A, Ryynänen K, Koivisto K, Riekkinen P. Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E ε4 allele. Neurology 1995;45:391-2.
30. Bondi MW, Salmon DP, Monsch AU, Galasko D, Butters N, Klauber MR, Thai LJ, Saitoh T. Episodic memory changes are associated with the APOE-ε4 allele in nondemented older adults. Neurology 1995;45: 2203-6.
31. Helkala EL, Koivisto K, Hänninen T, Vanhanen M, Kervinen JK, Mykkänen L, Kesäniemi YA, Laakso M, Riekkinen P. The association of apolipoprotein E polymorphism with memory: a population based study. Neuroscience Letters 1995;191:141-4.
32. Schmidt H, Schmidt R, Fazekas F, Semmler J, Kapeller P, Reinhart B, Kostner GM. Apolipoprotein E ε4 allelel in the normal elderly: neuropsychologic and brain MRI correlates. Clinical Genetics 1996;50:293-9.
33. Hyman BT, Gómez-Isla T, Briggs M, Chung H, Nichols S, Kohout F, Wallace R. Apolipoprotein E and cognitive change in an elderly population. Ann Neurol 1996;40(1):55-66.
34. Petersen RC, Smith GE, Ivnik RJ, Tangalos EG, Schaid DJ, Thibodeau SN, Kokmen E, Waring SC, Kurland LT. Apolipoprotein E status as a predictor of the Development of Alzheimer's disease in memory-impaired idndividuals. JAMA 1995;273(16):1274-8.
35. Tierney MC, Szalai PJ, Snow WG, Fisher MB, Tsuda T, Chi H, McLachlan DR, George-Hyslop, ST. A prospective study of the clinical utility of apoE geonotype in the prediction of outcome in patients with memory impairment. Neurology 1996;46:149-53.
36. Crook T, Bartus RT, Ferris SH, Whitchouse P, Cohen GD, Gershon S. Age-Associated memory impairment: proposed diagnostic criteria and measures of clinical change. Report of a National Institute of mental health work group. Developmental Neuropsychhology 1986;2:261-76.
37. Koivisto K, Reinikainen KJ, Hänninen T, Vanhanen M, Helkala e-L, Mykkänen L, Laakso M, Pyöräla K, Riekkinen PJ. Prevalence of age-associated memory impairment in a randomly selected population from eastern Finland. Neurology 1995;45:741-7.
38. Franceschi M, Canal N. AAMI (Letter). Neurology 1996;46:1490-1.
39. Barker A, Jones R, Jennison C. A prevalence study of Age-Associated Memory Impairment. British Journal of Psychiatry 1995;167:642-8.
40. Hänninen T, Koivisto K, Reinikainen KJ, Helkala EL, Soininen H, Mykkänen L, Laakso M, Riekkinen PJ. Prevalence of Ageing-associated Cognitive Decline in an elderly population. Age and Ageing 1996;25: 201-5.
41. Soininen HS, Partanen K, Pitkänen A, Vainio P, Hänninen F, Hallikainen M, Koivisto K, Reikkinen PJ. Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age-associated memory impairment: Correlation to visual and verbal memory. Neurology 1994;44:1660-8.
42. Parnetti L, Lowenthal DT, Presciutti O, Pelliccioli GP, Palumbo R, Gobbi G, Chiarini P, Palumbo B, Tarducci R, Senin U. 1H-MRS, MRI-based hippocampal volumetry, and 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease. J Am Geriatr Soc 1996;44(2): 133-8.
43. Hanninen T, Hallikainen M, Koivisto K, Helkala EL, Reinikainen KJ, Soininen H, Mykkanen L, Laakso M, Pyorala K, Riekkinen PJ. A follow-up study of age-associated memory impairment: neuropsychological predictors of dementia. J Am Geriatr Soc 1995;43(9): 1007-15.
44. Blesa R, Adroer R, Santacruz P, Ascaso C, Tolosa E, Oliva R. High apolipoprotein E ε4 allele frequency in Age-Related Memory Decline. Annals of Neurology 1996:39:548-51.
45. Forstl H, Hentschel F, Sattel H, Geiger-Kabisch C, Besthorn C, Czech C, Monning U, Beyreuther K. Age-associated memory impairment and early Alzheimer's disease. Only time will tell the difference. Arzneimittelforschung 1995;45(3A):394-7.
46. Palumbo B, Parnetti L, Nocentini G, Cardinali L, Brancorsini S, Riccardi C, Senin U. Apolipoprotein-E genotype in normal aging, age-associated memory impairment, Alzheimer's disease and vascular dementia patients. Neuroscience Letters 1997;231:59-61.
47. Reinman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Satoshi-Minoshima MS, Thibodeau SB, Osborne D. Preclinical evidence of Alhemer's disase in persons homozygous for the ε4 allele for apolipoprotein E. N Engl J Med 1996;334(12):752-8.
48. Small GW, Mazziotta JC, Collins T, Baxter LR, Phelps ME, Mandelkern MA, Kaplan A, La Rue A, Adamson CF, Chang L, Guze BH, Corder EH, Saunders AM, Haines JL, Periack-Vance MA, Roses AD. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzhemer disease. JAMA 1995;273(12):942-7.
49. Helkala EL, Koivisto K, Hänninen T, Vanhanen M, Kervinen K, Kuusisto J, Mykkänen L, Kesäniemi YA, Laakso M, Reikkinen P. Memory functions in human subjects with different apolipoprotein E phenotypes durin a 3-year population-based follow-up study. Neuroscience Letters 1996;204:177-80.
50. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphisms and atherosclerosis. Arterioesclerosis 1988;8:1-21.
51. Cauley JA, Eichner JE, Kamboh MI, Ferrell RE, Kuller LH. ApoE allele frequencies in younger (age 42-50) vs older (age 65-90) woman. Genet Epidemiol 1993;10: 27-34.
52. Menzel HJ, Kladetzky RG, Assmann G. Apolipoprotein E polymorphism and coronary heart disease. Atherosclerosis 1983;3:310-5.
53. Wang XL, Mccredie RM, Wilcken DEL. Polymorphisms of the apolipoprotein E gene and severity of coronary artery disease defined by angiography. Thromb Vasc Biol 15:1030-4.
54. Kosunen O, Talasniemi S, Lehtovirta M, Heinonen O, Helisalmi S, Mannermaa A, Paljärvi L, Ryynänen M, Riekkinen PJ, Soininen H. Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer's patients. Stroke 1995;26:743-8.
55. Shimano H, Ishibashi S, Murase T, Gotohoda T, Yamada N, Takaku F, Ohotomo E. Plasma apolipoprotein in patients with multi-infarct dementia». Atherosclerosis 1989;79:257-60.
56. Noguchi S, Murakami K. Apolipoprotein E genotype and Alzheimer's disease. Lancet 1993;342:737.
57. Frisoni GB, Bianchetti A, Govoni S, Trabucchi M, Calabresi L, Franceschini G. Association of apolipoprotein E E4 with vascular dementia. JAMA 1994;271 (17):1317.
58. Slooter AJC, Tang M, Van Duijn CM, Stern Y, Ott A, Bell K, Breteler MMB, Van Broeckhoven C, Tatermichi TK, Tycko BT, Hofman A, Mayeux R. Apolipoprotein E ε4 and the risk of dementia with stroke. JAMA 1997;277(10):818-21.
59. Kawamata J, Tanaka S, Shimohama S, Ueda K, Kimura J. Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia. J Neurol Neurosurg Psych 1994;54:1414-6.
60. Harrington CR, Louwagie J, Rossau R, Vanmechelen E, Perry RH, Perry EK, Xuereb JH, Roth M, Wischik M. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Am J Pathol 1994;145(6):1472-84.
61. Isoe K, Urakami K, Sato K, Takahashi K. Apolipoprotein E in patients with dementia of the Alzheimer type and vascular dementia. Acta Neurol Scand 1996; 93:133-7.
62. Helisami S, Linnaranta K, Lehtovirta M, Manneramaa A, Helinonen O, Ryynanen M, Reikkinen P, Soininen H. Apolipoprotein E polymorphism in patients with different neurodegenerative disorders. Neuroscience Letters 1996;205:61-4.
63. Sakoda S, Kuriyama M, Osame M, Takahashi K, Yamano T. Apolipoprotein E ε4. (Letter, comment) Neurology 1994;44:2420-1.
64. Scacchi R, De Bernardini L, Mantuano E, Donini LM, Vilardo T, Corbo RM. Apolipoprotein E (APOE) allele frequencies in late-onset sporadic Alzheimer's disease (AD), mixed dementia and vascular dementia: lack of association of ε4 allele with AD in Italian octogenarian patients. Neuroscience Letters 1995;201: 231-4.
65. Stengärd JH, Pekkanen J, Sulkava R, Ehnholm C, Erkinjuntti T, Nissinen A. Apolipoprotein E polymorphism, Alzheimer's disease and vascular dementia among elderly Finnish men. Acta Neurol Scand 1995; 92:297-8.
66. Bétard C, Robitaile Y, Gee M, Tiberghien D, Larrivée D, Roy P, Mortimer JA, Gauvreau D. Apo E allele frequencies in Alzheimer's disease, Lewy body dementia, Alzheimer's disease with cerebrovascular disease and vascular dementia. Neuroreport 1994;5(15): 1893-6.
67. Sulkava R, Kainulainen K, Verkkoniemi A, Niinistö L, Sobel E, Davanipour Z, Polvikoski T, Haltia M, Kontula K. APOE alleles in Alzheimer's disease and vascular dementia in a population aged 85+. Neurobiology of Aging 1996;17(3):373-6.
68. Higuchi S, Arai H, Nakagawa T, Muramatsu T, Sasaki H, Trojanowski JQ. The apolipoprotein E gene in Binswanger's disease and vascular dementia. Clin Genet 1996;50:459-61.
69. Mahieux F, Couderc R, Moulignier A, Bailleul S, Podrabinek N, Laudet J. Isoforme 4 de l'apolipoprotéine E et maladie d'Alzheimer spécificité et étude clinique. Paris: Rev Neurol 1995;151(4):231-9.
70. Pirttilä T, Lehtimäki T, Rinne J, Mattila K, Frey H, Nikkari T. The frequency fo apolipoprotein E4 allele is not increased in patients with probable vascular dementia. Acta Neurologica Scandinavica 19;93:352-4.
71. Junqué C. Demencia vascular: situación actual. Neurologia 1988:3(5):169-71.
72. Roman GC, Tatemichi TK. Vascular Dementia. (Letter). Neurology 1993;43:2160-1.
73. Pirttilä T, Lehetimaki T, Mattlia K. Apolipoprotein E E4 allele and Risk of Dementia. JAMA 1995;273(5): 375.
74. Roses AD, Saunders AM, Alberts MA, Strittmatter WJ, Schmechel D, Corder E, Pericack-Vance MA. Apolipoprotein E ε4 and risk of dementia. JAMA 1995; 273(5):374-5.
75. Pedro-Botet J, Sentí M, Nogués X, Rubiés-Prat J, Roquer J, D'Olhaberriague L, Olivé J. Lipoprotein and apolipoprotein profile in men with ischemic stroke. Stroke 1992;23:1556-2.
76. Kessler C, Spitzer C, Stauske D, Mende S, Stadimüller J, Walther R, Retting R. The apolipoprotein E and β-fibrinogen G/A-455 gene polumorphisms are associated with ischemic stroke involving large-vessel disease. Arterioscler Thromb Vasc Biol 1997;17:2880-4.
77. Courderc R, Mahieux F, Bailleul S, Fenelon G, Mary R, Fermanian J. Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease. A case-control study. Stroke 1993;24:661-664.
78. Greenberg SM, Rebeck W, Vonsattel JPG, Gómez-Isla T, Hyman BT. Apolipoprotein E ε4 and cerebral hamorrhage associated with amyloid angiopathy. Ann Neurol 1995;38(2):254-9.
79. Nicoll JAR, Burnett C, Love S, Graham DI, Dewar D, Ironside JW, Stewart J, Vinters HV. High frequency of apolipoprotein E ε2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol 1997;41(6): 716-1.
80. Alberts JM, Graffagnino C, Mcclenny C, Delong D, Strittmatter W, Saunders AM, Roses AD. ApoE genotypage and survival from intracerebral haemorrhage. The Lancet 1995;346:575.
81. Kuusisto J, Mykkänen L, Kervinen K, Kesäniemi YA, Laakso M. Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects. Arterioscler Thromb Vasc Biol 1995;15:1280-6.
82. Hofman A, Ott A, Breteler MMB, Bots ML, Slooter AJC, Van Harskamp F, Van Duijn CN, Van Broeckhoven C, Grobbee D. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterndam study. The Lancet 1997;349:151-4.
83. Kalmijn S, Feskens EJM, Launer LJ, Kromhout D. Cerebrovascular disease, the apolipoprotein e4 allele, and cognitive decline in a community-based study of elderly men. Stroke 1996;27(12):2230-5.